Upper Extremity and Muscle Oxygenation

March 15, 2024 updated by: Tuna Sümer, Saglik Bilimleri Universitesi

Investigation of the Correlation Between Upper Extremity Fatigue Level and Muscle Oxygenation

The aim of this study was to measure the acute change in oxygen saturation of skeletal muscle during resistance exercise in the upper extremity using near-infrared spectroscopy.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Our study aims to determine the acute oxygen response in the upper extremity muscles against a resistance exercise fatigue protocol, in order to demonstrate the effect of muscle oxygenation levels on the occurrence of symptoms such as fatigue in upper extremity use, and to provide reference information for the development of exercise programs.

It is known that resistance exercise increases resting energy expenditure and promotes fat oxidation for weight loss. Changes in cardiopulmonary function that occur in chronic diseases reduce oxygen uptake and decrease energy production, leading to increased fatigue. Resistance exercises in chronic diseases can regulate an individual's energy production capacity.

The main objective of our study is to investigate the effect of muscle oxygenation levels on the occurrence of symptoms such as fatigue by determining the oxygen response in the upper extremity muscles based on a resistance exercise protocol.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey
      • Istanbul, Turkey, 34010
        • Recruiting
        • Saglik Bilimleri University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Volunteering to participate in the study
  • Being over 18 years old
  • Having a Body Mass Index (BMI) value between 23-30 kg/m2
  • Absence of comorbid disease of the orthopedic, neurological, cardiopulmonery system

Exclusion Criteria:

  • Smoking / alcohol use
  • Presence of orthopedic disease effecting the upper extremity or previous surgery
  • Presence of cardiopulmonery disease that prevents exercise
  • Participants who performed resistance exercise regulary for more than 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Measurement of Upper Extremity Muscle Oxygenation
Measuring muscle oxygenation with fatigue protocol.
Device: Exercise follow up with near-infrared spectroscopy
Exercises will be followed by near-infrared spectroscopy. Fatigue protocol will be applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of Blood Pressure
Time Frame: Measurement will be made before and immediately after exercise.
Systolic/diastolic blood pressure will be determined with a digital blood pressure monitor and will be recorded in mmHg. Measurements will be taken via the right brachial artery in a comfortable position.
Measurement will be made before and immediately after exercise.
Saturation Measurement
Time Frame: Measurement will be made before and immediately after exercise.
Oxygen saturation will be measured with a pulse oximeter device and recorded on the form.
Measurement will be made before and immediately after exercise.
Muscle Oxygenation Measurement
Time Frame: Baseline.
MOXY Pro (Moxy 3, Firmware 1.1 Hutchinson MN, USA), a near-infrared spectroscopy device, will be used to measure the muscle oxygen rate (SmO2) and total hemoglobin amount (tHb) of the biceps brachii muscle.
Baseline.
Determination of Heart Rate
Time Frame: Measurement will be made before and immediately after exercise.
Heart rate will be determined with a digital blood pressure monitor and will be recorded in BPM.
Measurement will be made before and immediately after exercise.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Saglik Bilimleri Universitesi

Investigators

  • Study Director: Esra Pehlivan, Ass. Prof., Saglik Bilimleri Universitesi
  • Principal Investigator: Mehmet Burak Uyaroğlu, Pt.PhD(c), Saglik Bilimleri Universitesi
  • Study Chair: Tuna Sümer, PT, Saglik Bilimleri Universitesi
  • Study Chair: Melisa Eren, PT, Saglik Bilimleri Universitesi
  • Study Chair: Ceren Balıkcı, PT, Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

February 20, 2024

First Submitted That Met QC Criteria

February 27, 2024

First Posted (Actual)

March 5, 2024

Study Record Updates

Last Update Posted (Actual)

March 18, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • SaglikBilU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Oxygenation

Clinical Trials on Exercise follow up with near-infrared spectroscopy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe